Minimally invasive glaucoma surgery (MIGS) in NZ

Glaucoma surgery has come a long way since the days of Dr Louis de Wecker, described as the father of glaucoma filtration surgery in 1869. Sugar, Cairns...

The potential of ROCK inhibitors in the treatment of ocular disease

Rho-associated coiled-coil protein kinase (ROCK) inhibitors, have shown significant therapeutic potential for a wide range of ocular and non-ocular diseases....

Transforming eye care with AI

Artificial intelligence (AI) has delivered remarkable achievements: near human-level image classification, handwriting transcription and speech recognition....

Non-IOP factors in glaucoma management

Current glaucoma treatment focuses on the reduction of intraocular pressure, via medical management, laser trabeculoplasty or surgery. However, a significant...

Relative afferent pupillary defect: role and assessment

Relative afferent pupillary defect (RAPD) is one of the more important clinical signs in neuro-ophthalmic examination. Quite often its presence is the...

Antiparasitic efficacy of eyelid cleansers for Demodex blepharitis

Ocular surface infestation with Demodex mites is recognised as a significant risk factor for the development of chronic blepharitis. Although 50% tea tree...

Ocular manifestations in Down Syndrome

Down Syndrome (DS), trisomy of chromosome 21, is one of the most common genetic causes of intellectual disability. It affects 50-80 newborns annually in...

Corneal transplant rejection: principles and clinical management

Corneal transplantation is the most common form of tissue transplant in New Zealand with more than 300 cases performed annually. As widely-known, the primary...

18 articles found

Bottom Banner Advert